【摘 要】
：
Objective Giant sellar region tumors(diameter≥ 4.0cm)remain a therapeutic challenge with high mortality and morbidity,we described our surgical experience through diverse transcranial approaches for g
【机 构】
：
Department of Neurosurgery,The first affiliated hospital of Zhengzhou University 450052
【出 处】
：
中华医学会2015全国神经肿瘤学术大会
论文部分内容阅读
Objective Giant sellar region tumors(diameter≥ 4.0cm)remain a therapeutic challenge with high mortality and morbidity,we described our surgical experience through diverse transcranial approaches for giant sellar region tumors.
其他文献
Roger Barker is the Professor of Clinical Neuroscience at the University of Cambridge and is an Honorary Consultant Neurologist at Addenbrookes Hospital in Cambridge.
Dr.Cicchetti obtained her PhD in neurobiology at Université Laval in Québec (Canada) in 1998.In 2002,she completed a postdoctoral fellowship at Harvard Medical School in the field of cell replacement
Dr.Yus research has focused on the ionic and molecular mechanisms of neuronal cell death and neuroprotection after hypoxia and ischemia in vitro as well as in animal models.
Meng Li graduated from Peking University Health Science Centre (formerly Beijing Medical University),and obtained her PhD under the guidance of Professor Austin Smith at the Institute of Stem Cell Res
Prof.Xiao-Ming Xu received his Medical Diploma from Shanghai Second Medical University and Ph.D.in Anatomy/Neurobiology from The Ohio State University.
Yuan-shan Zeng is a professor of Histology and Embryology.He got his Ph.D.degree of Histology and Embryology in West China University of Medical Sciences in 1991.
Dr.Rongqiao He,a full professor of State Key Laboratory of Brain and Cognitive Science in Institute of Biophysics,Chinese Academy of Sciences,is interested in Neurochemistry,and works on the mechanism
目的 脑胶质瘤手术时判断肿瘤边界对于全切肿瘤非常重要,手术时肉眼下判断肿瘤边界较为困难,目前尚没有理想的方法,示踪染料结合配套的显微镜设备可能对于判断肿瘤边界具有重要价值,因此探索示踪染料结合配套的显微镜设备的使用具有重要意义.回顾2014年2月初至2014年3月中旬我们采用荧光素钠介导,在携带YELLOW560 滤光器的PENTERO 显微镜下切除8例高级别胶质瘤(III-IV 级),在此初步探
胶质母细胞瘤(Glioblastoma,GBM)患者的中位生存期仅为14.6个月.GBM 治疗效果差,因此迫切需要寻找新的更有效的治疗方法.在GBM 中经常出现表皮生长因子受体(Epidermal growth factor receptor,EGFR)扩增和表皮生长因子受体Ⅲ型突变体(Epidermal growth factor receptor variant Ⅲ,EGFRvⅢ),所以EGF
目的 术后残存的胶质瘤细胞往往导致肿瘤复发,并且其复发部位位于肿瘤切除后瘤腔壁2～3厘米的范围内.但是,由于肿瘤的侵袭性术中很难准确判定肿瘤的实际边界.荧光引导手术能在术中准确判定肿瘤的实际边界;同时,光动力学治疗也是一种有效辅助治疗方法.